• For Researchers

Turning evidence into impact: how CRUK are shaping immigration policy for research talent

We dig into the potential impacts of changes to the immigration system on research, and what CRUK are doing about it… We dig into the potential impacts of changes to the immigration system on research, and what CRUK are doing about it…

29 January 2026

• For Researchers

Opposites attract: what wound repair can tell us about cancer

One restores order, the other disrupts it – yet wound healing and cancer share the same cellular machinery. One restores order, the other disrupts it – yet wound healing and cancer share the same cellular machinery.

21 January 2026

• For Researchers

Making your research better: a patient perspective

Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways... Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways...

15 January 2026

• For Researchers

The switch and the Trojan horse: how viral vectors and synthetic enhancers could change glioblastoma treatment

Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic... Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic...

6 January 2026

• Policy & Insight

A historic step towards a smokefree Wales

A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion. A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion.

10 December 2025

• Policy & Insight
• Health & Medicine

First steps towards a targeted prostate cancer screening programme

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

28 November 2025

• For Researchers

Spin doctors: taking on the challenge of tissue-specific cell cycle control

A false start, a Nobel Prize and renewed hope – understanding cell cycle disruption over different tissues is complex. But we are getting there…    A false start, a Nobel Prize and renewed hope – understanding cell cycle disruption over different tissues is complex. But we are getting there…   

27 November 2025

• Health & Medicine
• Policy & Insight

How are cancer screening programmes decided in the UK?

The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided? The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided?

21 November 2025

• For Researchers

Exploring the survival tactics of childhood cancers

Lava-dwelling lizards, cells playing dead and a century-old evolutionary theory – understanding the way childhood cancers resist treatment is proving to be quite a ride... Lava-dwelling lizards, cells playing dead and a century-old evolutionary theory – understanding the way childhood cancers resist treatment is proving to be quite a ride...

18 November 2025